Article: CD38 Causes Age-Related NAD+ Loss and Mitochondrial Dysfunction: Preclinical Findings

PrevNext
Healthy Aging & Longevity Preclinical

CD38 Causes Age-Related NAD+ Loss and Mitochondrial Dysfunction: Preclinical Findings

Synopsis

NAD+ levels decrease with aging and are involved in age-related metabolic decline. To date, the mechanism responsible for the age-related reduction in NAD+ has not been elucidated. This study shows that the enzyme CD38, which breaks down NAD+, increases with age and causes this NAD+ loss. CD38 also leads to mitochondrial dysfunction partly by affecting SIRT3, a key mitochondrial protein. Additionally, CD38 degrades nicotinamide mononucleotide (NMN), a molecule used in NAD-boosting therapies. This identifies CD38 as a major regulator of NAD+ levels and a factor influencing NAD+ replacement treatments for aging and metabolic diseases.

Journal

Cell Metabolism

Share

Read more

Cellular Health

Autophagy Promotes Cell Survival by Maintaining Stable NAD+ Levels: Preclinical Findings

SynopsisAutophagy is a cellular process that removes damaged parts of the cell and is important for healthy aging. When autophagy is lost, NAD+ levels fall due to increased activity of enzymes that...

Read more
Liver Disease

Altered NAD+ and Glutathione Metabolism in Fatty Liver Disease: Preclinical Findings

SynopsisIn patients with non-alcoholic fatty liver disease (NAFLD), researchers identified altered liver metabolism, specifically increased demand for NAD+ and glutathione (GSH), a key antioxidant....

Read more